Project: Dietary supplements

Contact: Baruch Fischhoff

The Food and Drug Administration (FDA) is responsible for regulating the product labeling of dietary supplements. This research attempts to provide the FDA a systematic way to conduct risk-benefit analyses of the impacts of alternative regulatory policies on consumers of dietary supplements, either in general or for specific target populations. We posit that consumer information should be evaluated according to its impact on consumer decision-making. We offer an integrated empirical and analytic method for evaluating label information using a decision-specific model considering the supplement, the label health claim, the scientific evidence supporting the claim, and the population of consumers.